Reduced dermis thickness and AGE accumulation in diabetic abdominal skin

International Journal of Lower Extremity Wounds

Volumn 11, Issue 3, 2012, Pages 224-230

  Niu, Yiwen ^a   Cao, Xiaozan ^a   Song, Fei ^a   Xie, Ting ^a   Ji, Xiaoyun ^a   Miao, Mingyuan ^a   Dong, Jiaoyun ^a   Tian, Ming ^a   Lin, Yuan ^b   Lu, Shuliang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

advanced glycosylation end products (AGEs); diabetes mellitus; skin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BOVINE SERUM ALBUMIN; COLLAGEN FIBRIL; HYDROXYPROLINE; MALONALDEHYDE; MYELOPEROXIDASE;

ADULT; ARTICLE; CELL INFILTRATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DERMIS; ENZYME ACTIVITY; EPITHELIUM; FIBROBLAST; FULL THICKNESS SKIN GRAFT; HISTOLOGY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MORPHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; SKINFOLD THICKNESS;

ABDOMEN; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; FEMALE; FIBROBLASTS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; SERUM ALBUMIN, BOVINE; SKIN; SKIN DISEASES; TIME FACTORS; WOUND HEALING;

EID: 84866691995     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734612457570     Document Type: Article

References (31)

1. Zimmet P. Globalization, coca-colonization and the chronic disease epidemic: can the doomsday scenario be averted?. J Intern Med. 2000 ; 247: 301-310
2. Ahmed N. Advanced glycosylation end products: role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005 ; 67: 3-21
3. Perez MI, Cohn SR. Cutaneous manifestations of diabetes mellitus. J Am Acad Dermatol. 1994 ; 30: 519-531
4. King GL, Wakasaki H. Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes. Diabetes Care. 1999 ; 22: C31 - C37
5. Nishikawa T, Edelstein D, Du XL, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000 ; 404: 787-790
6. Singh R, Barden A, Mori T, Beilin L. Advanced glycosylation end-products: a review. Diabetologia. 2001 ; 44: 129-146
7. Alt N, Carson JA, Alderson NL, et al. Chemical modification of muscle protein in diabetes. Arch Biochem Biophys. 2004 ; 425: 200-206
8. Verzijl N, DeGroot J, Thorpe SR, et al. Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem. 2000 ; 275: 39027-39031
9. Sell DR, Lapolla A, Odetti P, Fogarty J, Monnier VM. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes. 1992 ; 41: 1286-1292
10. Hwang K, Kim DJ, Hwang SH. Thickness of Korean upper eyelid skin at different levels. J Craniofac Surg. 2006 ; 17: 54-56
11. Chen X, Lin W, Lu S, et al. Insulin prevents latent skin lesions by inhibiting the generation of advanced glycation end products in streptozotocin-induced diabetic rats. Endocr Pathol. 2009 ; 20: 163-169
12. Sajithlal GB, Chithra P, Chandrakasan G. Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem Pharmcol. 1998 ; 56: 1607-1614
13. Woessener JF. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys. 1961 ; 93: 440-447
14. Huttunen HJ, Fages C, Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem. 1999 ; 274: 19919-19924
15. Gilchrest BA. Prior chronic sun exposure decreases the lifespan of human skin fibroblasts in vitro. J Gerontol. 1980 ; 35: 537-541
16. Hiss J, Hirshberg A, Dayan DF, Bubis JJ, Wolman M. Aging of wound healing in an experimental model in mice. Am J Forensic Med Pathol. 1988 ; 9: 310-312
17. Rich L, Whittaker P. Collagen and picrosirius red staining: a polarized light assessment of fibrillar hue and spatial distribution. Braz J Morphol Sci. 2005 ; 22: 97-104
18. Bermudez DM, Herdrich BJ, Xu J, et al. Impaired biomechanical properties of diabetic skin: implications in pathogenesis of diabetic wound complications. Am J Pathol. 2011 ; 178: 2215-2223
19. Lateef H, Abatan OI, Aslam MN, Stevens MJ, Varani J. Topical pretreatment of diabetic rats with all-trans retinoic acid improves healing of subsequently induced abrasion wounds. Diabetes. 2005 ; 54: 855-861
20. Wertheimer E. Diabetic skin complications: a need for reorganizing the categories of diabetes-associated complications. Isr Med Assoc J. 2004 ; 6: 287-289
21. Bradley PP, Priebat DA, Christensen RD, et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982 ; 78: 206-209
22. Monboisse JC, Rittie L, Lamfarraj H, Garnotel R, Gillery P. In vitro glycoxidation alters the interactions between collagens and human polymorphonuclear leucocytes. Biochem J. 2000 ; 350: 777-783
23. Naskalski JW, Marcinkiewicz J, Drozdz R. Myeloperoxidase-mediated protein oxidation: its possible biological functions. Clin Chem Lab Med. 2002 ; 40: 463-468
24. Vlassara H, Brownlee M, Cerami A. Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications. Clin Chem. 1986 ; 32: B37 - B41
25. Pageon H. Reaction of glycation and human skin: the effects on the skin and its components, reconstructed skin as a model. Pathol Biol (Paris). 2010 ; 58: 226-231
26. Meng J, Sakata N, Takebayashi S, et al. Glycoxidation in aortic collagen from STZ-induced diabetic rats and its relevance to vascular damage. Atherosclerosis. 1998 ; 136: 355-365
27. Niu Y, Xie T, Ge K, Lin Y, Lu S. Effects of extracellular matrix glycosylation on proliferation and apoptosis of human dermal fibroblasts via the receptor for advanced glycosylated end products. Am J Dermatopathol. 2008 ; 30: 344-351
28. Lange-Sperandiol B, Sperandiol M, Nawroth P, Bierhaus A. RAGE signaling in cell adhesion and inflammation. Curr Pediatr Rev. 2007 ; 3: 1-9
29. Vlassara H. The AGE-receptor in the pathogenesis of diabetic complications. Diabetes Metab Res Rev. 2001 ; 17: 436-443
30. Schmidt AM, Yan SD, Yan SF, et al. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest. 2001 ; 108: 949-955
31. Chao CY, Zheng YP, Cheing GL. Epidermal thickness and biomechanical properties of plantar tissues in diabetic foot. Ultrasound Med Biol. 2011 ; 37: 1029-1038